- Home
- MAMA vs ZURA Comparison
MAMA vs ZURA Comparison
Compare MAMA & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMA
- ZURA
- Stock Information
- Founded
- MAMA 2010
- ZURA 2022
- Country
- MAMA United States
- ZURA United States
- Employees
- MAMA N/A
- ZURA N/A
- Industry
- MAMA Specialty Foods
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MAMA Consumer Staples
- ZURA Health Care
- Exchange
- MAMA Nasdaq
- ZURA Nasdaq
- Market Cap
- MAMA 323.1M
- ZURA 69.9M
- IPO Year
- MAMA N/A
- ZURA N/A
- Fundamental
- Price
- MAMA $8.84
- ZURA $1.30
- Analyst Decision
- MAMA Strong Buy
- ZURA Buy
- Analyst Count
- MAMA 3
- ZURA 7
- Target Price
- MAMA $10.33
- ZURA $14.33
- AVG Volume (30 Days)
- MAMA 251.7K
- ZURA 689.3K
- Earning Date
- MAMA 09-09-2025
- ZURA 08-08-2025
- Dividend Yield
- MAMA N/A
- ZURA N/A
- EPS Growth
- MAMA N/A
- ZURA N/A
- EPS
- MAMA 0.11
- ZURA N/A
- Revenue
- MAMA $128,745,000.00
- ZURA N/A
- Revenue This Year
- MAMA $17.24
- ZURA N/A
- Revenue Next Year
- MAMA $9.95
- ZURA N/A
- P/E Ratio
- MAMA $80.40
- ZURA N/A
- Revenue Growth
- MAMA 17.04
- ZURA N/A
- 52 Week Low
- MAMA $5.50
- ZURA $0.97
- 52 Week High
- MAMA $9.98
- ZURA $5.07
- Technical
- Relative Strength Index (RSI)
- MAMA 59.88
- ZURA 58.73
- Support Level
- MAMA $8.57
- ZURA $1.00
- Resistance Level
- MAMA $9.10
- ZURA $1.45
- Average True Range (ATR)
- MAMA 0.38
- ZURA 0.10
- MACD
- MAMA 0.00
- ZURA 0.02
- Stochastic Oscillator
- MAMA 70.90
- ZURA 66.67
About MAMA Mama's Creations Inc.
Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.